SIRT1 and cancer: Conversely, under hypoxic conditions, SIRT1 is a direct downstream target of hypoxia-inducible factor 1α (HIF-1α), which orchestrates with NF-κB pathway to promote cancer stem cell-like properties in ovarian cancer cells [9].